Fruquintinib cov nyiaj muag tau tshaj 200 lab nyob rau xyoo 2020, sofatinib muag ze li ntawm 32 lab hauv ob lub hlis

Tsis ntev los no, Hutchison Tshuaj tau tshaj tawm nws cov txiaj ntsig tau 2020 xyoo hauv nws lub vev xaib raug cai.

Raws li cov ntawv tshaj tawm kev tshaj tawm, nws thawj cov lag luam tsim, Fruquintinib Capsule, rau kev kho mob ntawm txoj kev mob qog nqaij hlav hauv lub cev, yuav tsim tag nrho cov nyiaj tau los ntawm 33,7 lab nyiaj daus las hauv 2020, uas yog nce ntxiv ntawm 91% piv nrog 17.6 lab Asmeskas las hauv 2019 .%, Hutchison Cov Chaw Muag Tshuaj tau hais tias qhov no yog vim muaj cov yam ntxwv tau teev tseg hauv 2020 Tuam Tshoj Cov Ntawv Pov Hwm Tshuaj Kho Mob Suav Teb. Hauv cov ntawv kho mob tshiab tshaj plaws, Fruquintinib kuj tseem tau sib cog lus sib cog lus sib cog lus, thiab tus nqi them rau kev kho mob yog 94,5 yuan (1mg / Capsule) thiab 378 yuan (5mg / tsiav tshuaj), uas yog kwv yees li 1984,5 yuan / kem thiab 2,646 yuan / thawv. Qhov kev pom zoo tseem siv tau mus txog Lub Kaum Ob Hlis 31, 2021.

Nyob rau tib lub sijhawm, cov ntawv tshaj tawm tau tshaj tawm tias Fruquintinib tseem tseem ua cov kev tshawb fawb soj ntsuam ntawm kev sib txuas ua ke nrog Sintilizumab ntawm Innovent Biologics thiab Tistilizumab ntawm BeiGene. Ntawm lawv, kev sib txuas ua ke nrog Sintilizumab yog Theem II cov kev tshawb fawb soj ntsuam tau tsim tsa hauv plaub lub hlis xyoo 2020 los kho 4 hom mob qog. Ntu Ib / II cov kev tshawb fawb txog kev kho mob sib xyaw ua ke nrog tislezolizumab yuav raug tsim tawm hauv Tebchaws Asmeskas hauv thawj ib nrab xyoo no rau kev kho mob siab heev, tsis kam lees tus mob cancer mis triple-negative.

Tsis tas li ntawd, Hutchison Cov Tshuaj Kho Mob kuj tau qhia tawm qhov kev muag khoom ntawm nws lwm txoj kev lag luam tshuaj Sofatinib. Thaum kawg ntawm Lub Kaum Ob Hlis 2020, Sofatinib tau pom zoo los ntawm National Food thiab Drug Administration rau kev kho mob ntawm kev mob siab tsis mob siab-necendic neuroendocrine. Mob Qog, qhov no yog qhov thib ob oncology tshuaj pom zoo los ntawm Hutchison Tshuaj hauv Suav. Lub Ib Hlis 2021, Sofatinib tau nkag mus rau cov ntawv thov soj ntsuam, thiab nws tiav cov nyiaj tau los ntawm 4.9 lab nyiaj daus las ob lub hlis tom qab nws pib tsim. Tam sim no, Sofatinib tau thov rau qhov kev ntsuas thib ob hauv Suav teb rau kev kho mob ntawm kev noj qab haus huv pancreatic neuroendocrine Cov Qog tau tab tom tshuaj xyuas thiab yuav zoo li yuav pom zoo nyob hauv Tebchaws Meskas thaum xaus xyoo 2021 lossis thaum ntxov 2022.

Nyob rau theem no, sofatinib tseem tab tom tshawb fawb soj ntsuam ntawm kev sib txuas ua ke nrog teriprizumab thiab tislezolizumab.

Ntxiv rau cov muag khoom lag luam yog fruquintinib thiab sofatinib, nyob rau xyoo 2020, Hutchison Tshuaj kuj tau xa daim ntawv teev npe tshuaj tshiab rau Syvotinib rau kev kho mob ntsws, uas tej zaum yuav pom zoo rau lub hlis thib ob ntawm lub xyoo no thaum ntxov. Vortinib yuav dhau los ua qhov thib peb oncology khoom tau txais kev pom zoo los ntawm Hutchison Pharmaceuticals thiab xav tau los ua thawj qhov kev xaiv MET inhibitor ntawm nws zoo ntawm Suav ua lag luam.

Nyob rau hauv cov ntsiab lus ntawm pab pawg kev tshaj tawm kev lag luam, Hutchison Pharmaceuticals tau hais tias lub tuam txhab' s tus kheej oncology tshuaj pab pawg tau nthuav dav rau ntau tshaj 420 tus neeg ua haujlwm (90 thaum xaus ntawm 2019), npog 2,300 lub tsev kho mob cancer thiab 20,000 tus kws kho mob.

Raws li lwm qhov chaw, Hutchison Tshuaj npaj yuav pib IPO ntawm Hong Kong Tshuag Pauv tau ntxov li thawj ib nrab ntawm xyoo 2021, thiab npaj yuav nce $ 500 lab. Ua ntej qhov no, Hutchison Tuam Tshoj Cov Tshuaj tau teev nyob rau ntawm Nasdaq hauv Tebchaws Asmeskas thiab London Tshuag Kev Lag Luam hauv Tebchaws Askiv.